Skip to main navigation Skip to search Skip to main content

Atrial Cardiopathy Worsens Neurological Severity, Raises Recurrence Rates, and Leads to Poor Vascular Outcomes in Patients With Embolic Stroke of Undetermined Source

  • Sung Hun Kim
  • , Hyung Jun Kim
  • , Hyun Kyung Kim
  • , Jang Hyun Baek
  • , Hahn Young Kim
  • , Yang Ha Hwang
  • , Sung Hyuk Heo
  • , Ho Geol Woo
  • , Hyungjong Park
  • , Sung Il Sohn
  • , Chi Kyung Kim
  • , Jin Man Jung
  • , Sang Hun Lee
  • , Jae Kwan Cha
  • , Hee Joon Bae
  • , Beom Joon Kim
  • , Bum Joon Kim
  • , Ji Sung Lee
  • , Hyo Suk Nam
  • , Jee Hyun Kwon
  • Wook Ju Kim, Hee Kwon Park, Man Seok Park, Kang Ho Choi, Jay Chol Choi, Joong Goo Kim, Chul Hoo Kang, Kwang Yeol Park, Young Seo Kim, Gyeong Moon Kim, Oh Young Bang, Jong Won Chung, Sung A. Chang, Tae Jin Song, Moo Seok Park, Min Kyoung Kang, Sun Uck Kwon, Woo Keun Seo

Research output: Contribution to journalArticlepeer-review

Abstract

Background and Purpose Atrial cardiopathy (AC) has been studied for its significance in embolic stroke of undetermined source (ESUS). This real-world study examines the relevance of AC in ESUS and its impact on stroke severity, recurrence, and major adverse cardiovascular events (MACEs). Methods We analyzed patients from stroke registries of South Korean centers (2014–2019) aged ≥20 years with acute ESUS or cardiogenic stroke without a definite embolic source. AC was defined by left atrial (LA) enlargement (diameter >40 mm in men and >38 mm in women; or LA volume index >34 mL/m2) or elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP, ≥250 pg/mL) levels. Patients were classified based on AC presence and stratified by the number of factors (AC groups 0, 1, and 2). Survival analysis in original and propensity score (PS)-matched cohorts assessed the impact of AC on stroke severity and vascular outcomes. Results Among 5,787 patients (65.9±13.9 years; female: 39.8%), 45.0% met the AC criteria (group 1: 40.3%, group 2: 4.7%). In the original cohort, AC group 2 was associated with increased stroke recurrence (hazard ratio [HR]: 1.76, 95% confidence interval [CI]: 1.06–2.92, P=0.03). After PSmatching, stroke recurrence remained significantly increased for AC (HR: 1.37, 95% CI: 1.04–1.79, P=0.02) and group 2 (HR: 1.94, 95% CI: 1.16–3.26, P=0.01). MACE outcomes increased in the group 2 patients (HR: 1.70, 95% CI: 1.07–2.70, P=0.02). NT-proBNP (HR: 0.97, 95% CI: 0.84–1.12, P=0.69) or LA enlargement (HR: 1.15, 95% CI: 0.89–1.49, P=0.28) alone were not predictive. AC correlated with longer hospital stays, and AC stratification with higher severity. Conclusion Especially with multiple factors, AC was associated with adverse clinical outcome in patients with ESUS. These findings underscore the importance of AC stratification in the management of ESUS patients.

Original languageEnglish
Pages (from-to)350-359
Number of pages10
JournalJournal of Stroke
Volume27
Issue number3
DOIs
StatePublished - Sep 2025

Bibliographical note

Publisher Copyright:
© 2025 Korean Stroke Society.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Atrial cardiopathy
  • Atrial remodeling
  • Cardiomyopathies
  • Cardiovascular diseases
  • Ischemic stroke
  • Major adverse cardiovascular event

Fingerprint

Dive into the research topics of 'Atrial Cardiopathy Worsens Neurological Severity, Raises Recurrence Rates, and Leads to Poor Vascular Outcomes in Patients With Embolic Stroke of Undetermined Source'. Together they form a unique fingerprint.

Cite this